Spotify, the world’s leading music streaming service, has always been known for its bold and innovative approach. In a groundbreaking move, Spotify has become the first streaming platform to embrace cannabis advertising through its new collaboration with Cresco Labs (CRLBF).

The campaign marks a significant convergence of two influential industries: cannabis and music streaming. Spotify boasts an impressive user base of over 220 million subscribers as of the first quarter of 2023, according to Statista, making it a prime target for advertisers seeking broad reach.

Cresco Labs, headquartered in Chicago, Illinois, is the owner of the renowned Sunnyside cannabis dispensary brand. The company believes that advertising on Spotify, one of the most frequented music streaming platforms, will effectively connect with cannabis enthusiasts—an unsurprising association given the historical link between music and marijuana.

Cory Rothschild, National Retail President of Cresco Labs, expressed the company’s enthusiasm for this groundbreaking partnership: “Audio streaming services represent a major opportunity for brands to reach large audiences in a targeted manner, and we’re excited to collaborate with Spotify to launch the first-ever cannabis ads from our Sunnyside national retail brand. Our Sunnyside advertising strategy is built on a data ecosystem enabling best-in-class targeting and measurement. Spotify’s platform will enable our marketing team to target our ads compliantly and profitably to our core shoppers in Illinois where we have a leading share in retail.”

Rothschild also highlighted the broader significance of this partnership, stating, “This important partnership is not only a step in normalizing cannabis, but it also showcases the sophistication and quality of marketing that we have unlocked at Cresco Labs.”

The Cresco ad campaign is expected to center on the Sunnyside “shopping experience.” It will feature 30-second audio advertisements and in-app digital banners, primarily focusing on the company’s proprietary e-commerce platform.

Spotify has earned a reputation for being an affordable platform for advertisers, with per-ad prices starting at just $250.

In this innovative partnership, Spotify and Cresco Labs are not only pushing boundaries but also contributing to the evolving landscape of cannabis advertising, marking a significant step toward its normalization.

 

Source: The Street

EXPLORE MORE NEWS

Major Corporations Investing in Cannabis

As cannabis legalization continues to spread across the country, major corporations are increasingly taking notice and investing in the industry. In April of 2023, a major beverage company announced a $100 million investment in a cannabis-infused drink startup, signaling the growing trend of large corporations entering the cannabis space.

Alabama Medical Cannabis Commission Makes Second Attempt to Grant Business Licenses

The Alabama Medical Cannabis Commission convened on Thursday for a renewed effort to allocate licenses to companies vying for participation in the state’s burgeoning medical cannabis industry.

Challenges in California’s Legal Marijuana Industry: High Costs and Compliance Hurdles

California’s legal marijuana industry is facing significant challenges, with high taxes and regulatory obstacles driving entrepreneurs towards the illicit market, according to the state’s Attorney General Rob Bonta. In a recent event held in Fresno, Bonta highlighted the excessive barriers to entry and operational costs as major roadblocks for businesses operating within the legal framework. He suggested that temporary tax reductions could be beneficial to ease the burden on legitimate operators.

Weed: Revisiting the captivating series hosted by Dr. Sanjay Gupta

Step into a realm where the vibrant green leaves of a plant hold not just the promise of transformation, but a catalyst for societal change. In the backdrop of a world skeptical yet curious, “Weed,” the mesmerizing series guided by the esteemed Dr. Sanjay Gupta, unfolds its narrative. Beyond its captivating storytelling lies a landmark endeavor that challenged perceptions, stirred conversations, and sparked a revolution in the realm of medical science. With a masterful blend of painstaking research, heartrending narratives, and insights from the brightest minds, this seven-episode odyssey embarks on an unprecedented exploration of medical cannabis. As the series aired, it ignited fervent discussions, captivating both public and critical acclaim. “Weed” was more than a documentary; it was a beacon that illuminated the potential to rewrite medical paradigms and the ways in which cannabis could be harnessed for healing. Its impact rippled through society, reshaping attitudes and inspiring advancements in cannabis research, legislation, and compassionate patient care.

Newsletter